Al MBA - RA Medical Quality Clinical
| RMEDDelisted Stock | USD 0.68 0.02 2.86% |
Insider
Al MBA is Quality Clinical of RA Medical Systems
| Phone | 760 804 1648 |
| Web | https://www.ramed.com |
RA Medical Management Efficiency
The company has return on total asset (ROA) of (0.4789) % which means that it has lost $0.4789 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.2525) %, meaning that it created substantial loss on money invested by shareholders. RA Medical's management efficiency ratios could be used to measure how well RA Medical manages its routine affairs as well as how well it operates its assets and liabilities.RA Medical Systems currently holds 124.17 K in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. RA Medical Systems has a current ratio of 4.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about RA Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark MD | Bluejay Diagnostics | N/A | |
| Fuad Ahmad | IRIDEX | 55 | |
| Patrick Mercer | IRIDEX | 53 | |
| Sanjay Ahuja | Tivic Health Systems | N/A | |
| CPA CPA | NanoVibronix | 68 | |
| Rob Scott | Nuwellis | N/A | |
| Mark Feinberg | Bluejay Diagnostics | N/A | |
| Ryan Sabia | Tivic Health Systems | 37 | |
| JD MBA | SINTX Technologies | 60 | |
| Kenneth CPA | Bluejay Diagnostics | 44 | |
| Mark Knudson | ReShape Lifesciences | 76 | |
| Sandra Eayrs | Nuwellis | N/A | |
| Leigh Salvo | IRIDEX | N/A | |
| Blake Gurfein | Tivic Health Systems | 41 | |
| Jennifer Ernst | Tivic Health Systems | 57 | |
| Jason Cook | Bluejay Diagnostics | 43 | |
| BS MS | SINTX Technologies | N/A | |
| Danielle Watson | Heart Test Laboratories | 43 | |
| Richard Ginn | Tenon Medical | 59 | |
| Katherine Tweden | ReShape Lifesciences | 64 | |
| Jody Dahlman | ReShape Lifesciences | N/A | |
Management Performance
| Return On Equity | -3.25 | |||
| Return On Asset | -0.48 |
RA Medical Systems Leadership Team
Elected by the shareholders, the RA Medical's board of directors comprises two types of representatives: RA Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RMED. The board's role is to monitor RA Medical's management team and ensure that shareholders' interests are well served. RA Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RA Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tiah Reppas, Chief VP | ||
| Jonathan McGuire, CEO Director | ||
| Maria Villanueva, VP Officer | ||
| Al MBA, Quality Clinical | ||
| Brian Conn, Principal CFO |
RMED Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RA Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.25 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (307.60) % | |||
| Current Valuation | (8.89 M) | |||
| Shares Outstanding | 6.46 M | |||
| Shares Owned By Insiders | 36.84 % | |||
| Shares Owned By Institutions | 11.00 % | |||
| Number Of Shares Shorted | 81.45 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 604.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |